MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202311083728 A) filed by Bhawana Mishra, New Delhi, on Dec. 8, 2023, for 'antitussive composition comprising terminalia chebula, terminalia bellirica, and phyllanthus emblica in specified ratios.'
Inventor(s) include Bhawana Mishra.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "This invention pertains to an antitussive pharmaceutical composition utilizing Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica in specified ratios. Chronic coughing, often indicative of underlying respiratory ailments, necessitates effective antitussive remedies. Conventional medications may bear adverse side effects, prompting interest in herbal alternatives. This invention harnesses the antitussive properties of Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica, key components of traditional medicine, to create diverse formulations aiming to suppress cough reflexes. Experimental data exhibits the efficacy of formulations in managing cough symptoms, showcasing substantial reduction in frequency and intensity among participants. The results validate the composition's effectiveness in alleviating cough symptoms and enhancing respiratory function."
Disclaimer: Curated by HT Syndication.
